Tag: pandemic

Developers of Oxford-AstraZeneca Vaccine Tied to UK Eugenics Movement

For instance, mainstream media has had little, if anything, to say about the role of the vaccine developers’ private company – Vaccitech – in the Oxford-AstraZeneca partnership, a company whose main investors include former top Deutsche Bank executives, Silicon Valley behemoth Google and the UK government. All of them stand to profit from the vaccine alongside the vaccine’s two developers, Adrian Hill and Sarah Gilbert, who retain an estimated 10% stake in the company. Another overlooked point is the plan to dramatically alter the current sales model for the vaccine following the initial wave of its administration, which would see profits soar, especially if the now obvious push to make COVID-19 vaccination an annual affair for the foreseeable future is made reality.

Yet, arguably most troubling of all is the direct link of the vaccine’s lead developers to the Wellcome Trust and, in the case of Adrian Hill, the Galton Institute, two groups with longstanding ties to the UK Eugenics movement. The latter organization, named for the “father of eugenics” Francis Galton, is the re-named UK Eugenics Society, a group notorious for its promotion of racist pseudoscience and efforts to “improve racial stock” by reducing the population of those deemed inferior for over a century.

The ties of Adrian Hill to the Galton Institute should raise obvious concerns given the push to make the Oxford-AstraZeneca vaccine he developed with Gilbert the vaccine of choice for the developing world, particularly countries in Latin America, South and Southeast Asia and Africa, the very areas where the Galton Institute’s past members have called for reducing population growth.

In the final installment of this series on Operation Warp Speed, the US government’s vaccination effort, and race, the Oxford-AstraZeneca vaccine’s ties to Eugenics-linked institutions, the secretive role of Vaccitech, and the myth of the vaccine’s sale being “non-profit” and altruistically motivated are explored in detail.

Keep reading

The Pandemic Has Led To More Drug Overdoses In A 12-Month Period Than At Any Point In US History

The United States recorded over 81,000 drug overdose deaths in a 12-month stretch, the worst year-long total reported in American history.

The U.S. has long been struggling to combat the opioid epidemic, but experts say that the total between May 2019 and May 2020, published in a CDC report last week, can be at least partially attributed to the coronavirus pandemic.

Specifically, experts attribute the total to the pandemic’s disruption of in-person treatment and recovery when it began to spread nationwide in March. Americans who suffered from drug use were also increasingly likely to use drugs alone once they entered quarantine and were kept away from others, upping the risk that an overdose would prove fatal since nobody was available to contact already-burdened emergency services, the CDC report outlines.

Experts also said that already-lethal drugs themselves have become even more dangerous; since the pandemic caused supply problems for cartels and dealers, they mixed extremely potent drugs like fentanyl into heroin, cocaine and methamphetamine.

Keep reading

Lockdowns don’t work. It remains a mystery as to why the world entered one

More evidence against the unexpected and unprecedented world and WHO response to the crisis in 2020 is provided in this 91-page 2019 WHO report entitled “Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza”. The word “lockdown” (one form of a non-pharmaceutical intervention or NPI) does not appear in this report. Nor does the WHO report even recommend masks (a favourite 2020 NPI) in case of an epidemic, though it does advocate their use for symptomatic individuals.

On the effect of NPIs, the report stated: “The evidence base on the effectiveness of NPIs in community settings is limited, and the overall quality of evidence was very low for most interventions. There have been a number of high-quality randomised controlled trials (RCTs) demonstrating that personal protective measures such as hand hygiene and face masks have, at best, a small effect on influenza transmission, although higher compliance in a severe pandemic might improve effectiveness” (emphasis added). Yet, for COVID-19, NPIs were recommended in bundles by WHO and other experts.

As is universally acknowledged, the WHO is the apex body for advice and guidance for health problems. It houses leading epidemiological experts and before COVID, they were advocating policies reminiscent of earlier confrontations with viruses.

Given this history, it remains a mystery as to why the world entered into a lockdown. In my paper, I report the result of various studies on the effectiveness of lockdowns; except for a few, most of these studies report that the lockdowns were highly successful in saving hundreds of thousands of lives. Since the average death rate from COVID is 2.5 per cent, these results imply that somewhere between 10 to 20 million less infections resulted from this unnatural experiment.

Keep reading

Doctor reportedly has severe allergic reaction to Moderna COVID-19 vaccine

A Boston doctor suffered a serious allergic reaction to Moderna’s coronavirus vaccine, the first of its kind documented, a report said Friday.

Dr. Hossein Sadrzadeh, a geriatric oncologist at Boston Medical Center, became dizzy and felt his heart racing minutes after receiving the vaccine on Thursday, he told The New York Times.

“It was the same anaphylactic reaction that I experience with shellfish,” Dr. Sadrzadeh told the paper, noting that his tongue became numb, his blood pressure plummeted and he broke into a cold sweat.

“I don’t want anybody to go through that.”

Keep reading

Researchers Are Looking At Cannabis As A Potential Way To Prevent COVID-19

Two Canadian researchers think that a special strain of cannabis might potentially be a valuable tool in the fight against COVID-19.

The researchers, Olga and Igor Kovalchuck have reportedly been developing and testing a novel cannabis strain for years, except with the goal of creating a strain that helps to combat cancer and inflammation. When the pandemic hit, the duo started to focus their efforts on how the strain might be used to help fight COVID-19.

The duo’s work was published in an April issue of the online medical journal Preprints.

“Similar to other respiratory pathogens, SARS-CoV2 is transmitted through respiratory droplets, with potential for aerosol and contact spread. It uses receptor-mediated entry into the human host via angiotensin-converting enzyme II (ACE2) that is expressed in lung tissue, as well as oral and nasal mucosa, kidney, testes, and the gastrointestinal tract,” reads the study. “Modulation of ACE2 levels in these gateway tissues may prove a plausible strategy for decreasing disease susceptibility.”

After looking at the research done on cannabis and COVID by other scientists, they were able to determine that cannabis, a special strain in particular, could potentially block COVID-19 from entering a person’s body to begin with.

It all comes down to our body’s ACE2 receptors, which works sort of like doorways into our bodies for the virus. In the case of the Kovalchuck’s work, cannabis would be used to decrease the level of ACE2 gene expression, essentially temporarily closing the doors to the virus.

Keep reading